Author
Listed:
- Argen Mamazhakypov
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
- Natascha Sommer
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
- Birgit Assmus
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany
Department of Cardiology, Justus-Liebig University, 35390 Giessen, Germany)
- Khodr Tello
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
- Ralph Theo Schermuly
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
- Djuro Kosanovic
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany
Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia)
- Akpay Sh. Sarybaev
(Department of Mountain and Sleep Medicine and Pulmonary Hypertension, National Center of Cardiology and Internal Medicine, Bishkek 720040, Kyrgyzstan)
- Norbert Weissmann
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
- Oleg Pak
(Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany)
Abstract
Right ventricular (RV) function is the main determinant of the outcome of patients with pulmonary hypertension (PH). RV dysfunction develops gradually and worsens progressively over the course of PH, resulting in RV failure and premature death. Currently, approved therapies for the treatment of left ventricular failure are not established for the RV. Furthermore, the direct effects of specific vasoactive drugs for treatment of pulmonary arterial hypertension (PAH, Group 1 of PH) on RV are not fully investigated. Pulmonary artery banding (PAB) allows to study the pathogenesis of RV failure solely, thereby testing potential therapies independently of pulmonary vascular changes. This review aims to discuss recent studies of the mechanisms of RV remodeling and RV-directed therapies based on the PAB model.
Suggested Citation
Argen Mamazhakypov & Natascha Sommer & Birgit Assmus & Khodr Tello & Ralph Theo Schermuly & Djuro Kosanovic & Akpay Sh. Sarybaev & Norbert Weissmann & Oleg Pak, 2021.
"Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model,"
IJERPH, MDPI, vol. 18(16), pages 1-21, August.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:16:p:8297-:d:608926
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Swee Heng Milon Pang & Joshua D’Rozario & Senora Mendonca & Tejasvini Bhuvan & Natalie L. Payne & Di Zheng & Assifa Hisana & Georgia Wallis & Adele Barugahare & David Powell & Jai Rautela & Nicholas D, 2021.
"Mesenchymal stromal cell apoptosis is required for their therapeutic function,"
Nature Communications, Nature, vol. 12(1), pages 1-19, December.
- Rongmao Qiu & Xiaojing Li & Kui Huang & Weizhe Bai & Daoning Zhou & Gang Li & Zhao Qin & Yang Li, 2023.
"Cis-trans isomerization of peptoid residues in the collagen triple-helix,"
Nature Communications, Nature, vol. 14(1), pages 1-12, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:16:p:8297-:d:608926. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.